Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-24-000002
Filing Date
2024-11-04
Accepted
2024-11-04 19:03:33
Documents
10

Document Format Files

Seq Description Document Type Size
1 SC 13G endoinc_13gnov2024.htm SC 13G 74441
2 JOINT FILING AGREEMENT endoinc_jointfa13gnov2024.htm EX-1 5954
3 GRAPHIC image_001.gif GRAPHIC 348
4 GRAPHIC image_002.gif GRAPHIC 369
5 GRAPHIC image_006.gif GRAPHIC 102
6 GRAPHIC image_007.gif GRAPHIC 94
7 GRAPHIC image_008.gif GRAPHIC 106
8 GRAPHIC image_009.gif GRAPHIC 129
9 GRAPHIC image_010.gif GRAPHIC 132
10 GRAPHIC image_011.gif GRAPHIC 135
  Complete submission text file 0000905718-24-000002.txt   85076
Mailing Address ONE BRYANT PARK 38TH FLOOR NEW YORK NY 10036
Business Address ONE BRYANT PARK 38TH FLOOR NEW YORK NY 10036 212-500-3123
MARATHON ASSET MANAGEMENT LP (Filed by) CIK: 0001279913 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13G

Mailing Address 1400 ATWATER DRIVE MALVERN PA 19355
Business Address 1400 ATWATER DRIVE MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Subject) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94675 | Film No.: 241425128
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)